IPSEN (IPSEY) News Today $34.61 +1.25 (+3.75%) As of 08/28/2025 12:27 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartDividendHeadlinesShort InterestBuy This Stock IPSEY Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period IPSEN (OTCMKTS:IPSEY) Share Price Passes Above 200-Day Moving Average - Time to Sell?August 25, 2025 | marketbeat.comIPSEN (OTCMKTS:IPSEY) Sets New 1-Year High - Here's What HappenedAugust 21, 2025 | marketbeat.comIPSEN (OTCMKTS:IPSEY) Share Price Crosses Above 200-Day Moving Average - Here's WhyAugust 16, 2025 | marketbeat.comIPSEN (OTCMKTS:IPSEY) Shares Pass Above 200 Day Moving Average - Time to Sell?August 8, 2025 | marketbeat.comIpsen S.A. publishes its 2025 Half-Year Report (half-year ended 30 June 2025)July 31, 2025 | globenewswire.comShort Interest in IPSEN (OTCMKTS:IPSEY) Declines By 90.5%July 30, 2025 | marketbeat.comIPSEN (OTCMKTS:IPSEY) Share Price Crosses Above 200 Day Moving Average - Should You Sell?July 26, 2025 | marketbeat.comIPSEN (OTCMKTS:IPSEY) Reaches New 52-Week High - Should You Buy?July 24, 2025 | marketbeat.comCabometyx® approved in the EU for previously treated advanced neuroendocrine tumorsJuly 24, 2025 | theglobeandmail.comIPSEN (OTCMKTS:IPSEY) Shares Cross Above Two Hundred Day Moving Average - What's Next?July 18, 2025 | marketbeat.comIPSEN (OTCMKTS:IPSEY) Share Price Passes Above Two Hundred Day Moving Average - What's Next?July 10, 2025 | marketbeat.comIpsen - Half year statement - 2025 06 30 - Yahoo FinanceJuly 9, 2025 | finance.yahoo.comIPSEN (OTCMKTS:IPSEY) Stock Crosses Above Two Hundred Day Moving Average - Here's WhyJuly 2, 2025 | marketbeat.comIpsen S.A. (IPSEY) stock price, news, quote & history - Yahoo FinanceJune 26, 2025 | au.finance.yahoo.comIpsen Pharma: Ipsen receives positive CHMP opinion for Cabometyx in previously treated advanced neuroendocrine tumorsJune 20, 2025 | finanznachrichten.deIpsen S.A. (OTCMKTS:IPSEY) Short Interest Down 45.5% in MayJune 15, 2025 | marketbeat.comIpsen S.A. (OTCMKTS:IPSEY) Announces Dividend Increase - $0.29 Per ShareJune 3, 2025 | marketbeat.comShort Interest in Ipsen S.A. (OTCMKTS:IPSEY) Declines By 26.7%June 2, 2025 | marketbeat.comIpsen S.A. - Initiation of the share buy-back programJune 2, 2025 | globenewswire.comIpsen (OTCMKTS:IPSEY) Shares Cross Above 200-Day Moving Average - What's Next?May 30, 2025 | marketbeat.comIpsen (OTCMKTS:IPSEY) Stock Passes Above Two Hundred Day Moving Average - Here's WhyMay 23, 2025 | marketbeat.comIpsen S.A. - Annual General Meeting held on 21 May 2025May 21, 2025 | globenewswire.comGENFIT to receive a €26.5 million milestone payment following the approval of pricing and reimbursement of Ipsen's Iqirvo® in ItalyMay 20, 2025 | globenewswire.comIpsen Pharma: Ipsen appoints Laura Réveillon as EVP, Strategy & TransformationMay 6, 2025 | finanznachrichten.deIpsen (OTCMKTS:IPSEY) Stock Passes Above Two Hundred Day Moving Average - Time to Sell?May 5, 2025 | marketbeat.comIpsen S.A. - Formalities for making available and consulting preparatory documents to the 2025 Annual General MeetingApril 30, 2025 | globenewswire.comIpsen S.A. (OTCMKTS:IPSEY) Short Interest Up 2,750.0% in AprilApril 28, 2025 | marketbeat.comIpsen S.A. (IPSEY) Q1 2025 Earnings Call TranscriptApril 16, 2025 | seekingalpha.comIpsen delivers strong sales in the first quarter 2025 and confirms its full-year guidanceApril 16, 2025 | markets.businessinsider.comIpsen (OTCMKTS:IPSEY) Hits New 1-Year Low - Here's WhyApril 9, 2025 | marketbeat.comIpsen publishes its 2024 Universal Registration DocumentApril 8, 2025 | finance.yahoo.comIpsen (OTCMKTS:IPSEY) Stock Price Crosses Above 200-Day Moving Average - Here's WhyApril 6, 2025 | marketbeat.comRBC Capital Sticks to Its Buy Rating for Ipsen (0MH6)April 2, 2025 | markets.businessinsider.comIpsen (OTCMKTS:IPSEY) Share Price Crosses Above 200-Day Moving Average - Here's What HappenedMarch 20, 2025 | marketbeat.comIpsen Pharma: Ipsen announces issuance of €500 million inaugural Rated Public BondMarch 19, 2025 | finanznachrichten.deIpsen announces issuance of €500 million inaugural Rated Public BondMarch 19, 2025 | finance.yahoo.comIpsen S.A. (OTCMKTS:IPSEY) Short Interest Down 80.0% in FebruaryMarch 13, 2025 | marketbeat.comIpsen appoints Olivia Brown as Executive Vice-President, Global Head of NeurotoxinsMarch 12, 2025 | markets.businessinsider.comIpsen - February 2025 - Monthly information relative to the total number of voting rights and shares composing the share capitalMarch 7, 2025 | uk.finance.yahoo.comIpsen (OTCMKTS:IPSEY) Share Price Passes Above Two Hundred Day Moving Average - Here's What HappenedMarch 7, 2025 | marketbeat.comMarengo Therapeutics Announces Second Drug Candidate Nomination from Strategic Collaboration with IpsenMarch 3, 2025 | finance.yahoo.comShort Interest in Ipsen S.A. (OTCMKTS:IPSEY) Grows By 400.0%February 28, 2025 | marketbeat.comBarclays Reaffirms Their Hold Rating on Ipsen (0MH6)February 18, 2025 | markets.businessinsider.comUBS Sticks to Their Buy Rating for Ipsen (0MH6)February 14, 2025 | markets.businessinsider.comIpsen SA (IPSEF) Full Year 2024 Earnings Call Highlights: Strong Sales Growth and Strategic ...February 14, 2025 | finance.yahoo.comIpsen (OTCMKTS:IPSEY) Stock Crosses Above Two Hundred Day Moving Average - Here's What HappenedFebruary 14, 2025 | marketbeat.comIpsen targets 5%+ sales growth and 30%+ margin for 2025 amid strong pipeline and launchesFebruary 13, 2025 | msn.comIpsen S.A. (IPSEY) Q4 2024 Earnings Call TranscriptFebruary 13, 2025 | seekingalpha.comIpsen stock falls following mixed Q4 resultsFebruary 13, 2025 | msn.comIpsen delivers solid results in 2024, driven by strong performance across all therapeutic areas, and provides guidance for 2025February 13, 2025 | markets.businessinsider.com Get IPSEN News Delivered to You Automatically Sign up to receive the latest news and ratings for IPSEY and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. IPSEY Media Mentions By Week IPSEY Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. IPSEY News Sentiment▼0.221.03▲Average Medical News Sentiment IPSEY News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. IPSEY Articles This Week▼11▲IPSEY Articles Average Week Get the Latest News and Ratings for IPSEY and Related Stocks Enter your email address to receive the latest news and analysts' ratings for IPSEN and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies BeOne Medicines News Sandoz Group News Summit Therapeutics News Merck KGaA News Shionogi & Co., Ltd. Unsponsored ADR News United Therapeutics News Neurocrine Biosciences News Orion OYJ News Madrigal Pharmaceuticals News Corcept Therapeutics News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:IPSEY) was last updated on 8/29/2025 by MarketBeat.com Staff From Our PartnersMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IPSEN Please log in to your account or sign up in order to add this asset to your watchlist. Share IPSEN With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access